News

Lung Cancer Screening at Duke Radiology

Duke University Medical Center has been designated a Lung Cancer Screening Center by the American College of Radiology (ACR).

The ACRLCSClogo Lung Cancer Screening Center designation recognizes institutions such as Duke that are committed to practice safe, effective diagnostic care for individuals at the highest risk for lung cancer.

In order to receive this elite distinction, facilities must be accredited by the ACR in computed tomography (CT), as well as undergo a rigorous assessment of its lung cancer screening program, including CT protocols, infrastructure, counseling, and follow-up patient care.

In December 2013, the United States Preventive Services Task Force recommended screening of adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years.  The Centers for Medicare & Medicaid Services has recently approved lung cancer CT screening for high-risk patients.

Duke University Medical Center has had a Lung Cancer Screening Program in place since 2011 and is one of the first programs in the Triangle to qualify as an ACR-designated screening center. The Program is a multidisciplinary approach to lung cancer prevention, diagnostics, and management directed by Drs. Jared Christensen (Department of Radiology, Imaging Director) and Betty Tong (Department of Thoracic Surgery, Clinical Director).

Dr. Jared Christensen, the Imaging Director of the Duke Lung Cancer Screening Program, encourages patients to discuss lung cancer screening with their physicians as a part of routine medical care to determine eligibility:  “Lung cancer is the nation’s leading cancer killer – resulting in more deaths than breast, colon and prostate cancers combined. Lung cancer screening with low-dose computed tomography (CT) scans significantly reduces lung cancer deaths through early detection, when cancers are in their most treatable stage. We are pleased to offer this important imaging service as part of Duke’s comprehensive approach to cancer care.”

SHARE: